GC Angels led the pre-seed round, which will fund team growth and platform development.
"Our goal is to democratise the traditional bra fitting experience, making it accessible and personalised for everyone. The funding from GC Angels will help us to grow Brarista and reduce the £10bn annual cost of lingerie returns that take place due to poor fit. With the support of Ranvir and the GC Angels team, we’re looking to expand into new product categories, empower consumers, and have a real impact in the lingerie and fashion markets."
The funding will support the design, manufacturing, and field trials of a non-antibiotic treatment for Helicobacter pylori.
"I’m excited by the possibility for this treatment to help a lot of people, benefiting their overall health and avoiding the misery of side effects from antibiotics."
The pre-seed round was led by GC Angels alongside Innovate UK to fund platform development and team expansion.
"Our goal is to provide a holistic approach to mental and physical health, allowing users to take control of their well-being in a way that is tailored to their unique needs. The funding from GC Angels will allow us to integrate AI technology into our platform and improve our solution, helping even more people manage their health and performance across industries like sports and education."
"The widespread success of GLP-1s for weight management has certainly changed the management landscape in obesity, but high discontinuation rates mean that they represent an imperfect solution to a complex issue. With the funding secured in this round, we will be able to significantly progress our path to clinic for DBL’s lead candidates which target greater fat vs muscle loss and provide a much-required alternative to GLP-1s for the majority of users forced to discontinue GLP-1s due to intolerance."
.png)